Honeycombing in the lungs refers to a pattern of clustered, thick-walled cysts visible on a CT scan, signaling that lung tissue has been replaced by scar tissue in its most advanced form. The cysts typically measure roughly 3 to 10 millimeters across and concentrate near the outer edges of the lungs, giving the affected areas an appearance strikingly similar to a cross-section of a beehive. Seeing the word “honeycombing” on a radiology report is unsettling, and for good reason: it marks a stage of lung scarring that is not reversible with current medicine. But understanding what it means, what caused it, and what can still be done makes a real difference in how you navigate the road ahead.
What Honeycombing Actually Looks Like on a Scan
On a high-resolution CT scan, honeycombing shows up as groups of small, air-filled spaces packed closely together, each surrounded by clearly defined walls. These cysts cluster predominantly along the base and outer surfaces of the lungs, though they can spread more widely as disease progresses. Underneath the imaging, what has happened at the tissue level is a combination of collapsed, scarred air sacs and widened air passages that have lost their normal structure entirely.1European Journal of Radiology. Honeycombing on CT; its definition, pathologic correlation, and future direction of its diagnosis The term was originally used to describe the appearance of various lung diseases that produced multiple cysts when examined with the naked eye, but it now specifically refers to end-stage pulmonary fibrosis.2PubMed. Honeycomb lung: history and current concepts
Radiologists look carefully at where the honeycombing sits and how much of the lung it occupies, because both details influence the diagnosis and the outlook. A pattern concentrated at the lung bases and periphery, combined with other signs of scarring, points strongly toward one particular disease: idiopathic pulmonary fibrosis, or IPF. When honeycombing appears alongside reticular (net-like) markings and sits in a subpleural, basal distribution without features that would suggest another condition, it meets the criteria for what radiologists call a “definite UIP pattern” on imaging, which is the hallmark of IPF.3European Respiratory Review. Imaging: how to recognise idiopathic pulmonary fibrosis
How Lung Tissue Reaches This Point
Healthy lungs are made up of millions of tiny air sacs that stretch and contract with each breath, allowing oxygen to pass into the bloodstream. In diseases that cause honeycombing, the cells lining those air sacs become repeatedly injured. In a normal wound, the repair process lays down a small amount of scar tissue and then stops. In pulmonary fibrosis, the repair process goes haywire. The injured lining cells release signals that recruit scar-forming cells called fibroblasts, which then transform into a more aggressive type that churns out collagen and other structural proteins far beyond what is needed.4European Respiratory Review. Epithelial fibroblast triggering and interactions in pulmonary fibrosis Over time, this excess scar tissue stiffens the lung and destroys the delicate architecture of the air sacs.
Current thinking holds that IPF arises from repeated rounds of this kind of injury and abnormal healing, especially in people who are genetically predisposed and older.5PubMed Central. Mechanisms of alveolar epithelial injury, repair, and fibrosis The result is a lung that gradually loses its ability to move oxygen, producing the breathlessness and cough that bring people to the doctor in the first place. Honeycombing represents the final stage of this process, where enough tissue has been replaced by scar and cysts that the original architecture is gone for good.
What Conditions Cause Honeycombing
IPF is the disease most strongly linked to honeycombing, but it is not the only one. Other forms of lung scarring can reach this stage too, including fibrosis caused by autoimmune diseases like rheumatoid arthritis and scleroderma, chronic hypersensitivity pneumonitis (a reaction to inhaled allergens like mold or bird proteins), asbestosis, and certain drug-induced lung injuries. Pneumoconioses, a group of occupational lung diseases caused by inhaling mineral dusts over many years, can also progress to honeycombing in advanced cases.
This is why radiologists and lung specialists do not stop at spotting honeycombing on a scan. They need to determine what disease is driving the scarring, because the treatment approach and outlook differ. A patient with rheumatoid arthritis-related lung disease may benefit from immunosuppression, while someone with IPF will not. Distinguishing between these causes often requires pulling together imaging, lab work, clinical history, and sometimes a lung biopsy.
Symptoms That Typically Accompany It
By the time honeycombing is visible on a scan, most people are experiencing noticeable symptoms. Progressive breathlessness, especially during physical activity, is the most common complaint. A persistent dry cough that does not respond to typical treatments is another hallmark. As the disease advances, everyday tasks like climbing stairs or walking across a parking lot can leave you winded.
One physical sign that doctors listen for is a distinctive crackling sound heard through a stethoscope, often described as the sound of slowly pulling apart a strip of Velcro. In one study of patients with interstitial lung disease, all of those who had a definite UIP pattern on CT and a final diagnosis of IPF had these Velcro crackles on examination. Patients with these crackles also tended to have worse lung function at the time of diagnosis.6PubMed Central. Auscultation of Velcro Crackles Is Associated With Usual Interstitial Pneumonia Finger clubbing, where the tips of the fingers become rounded and the nails curve downward, is another sign that sometimes develops in advanced fibrotic lung disease.
How the Diagnosis Is Made
Reaching a confident diagnosis when honeycombing is present is harder than you might expect. The imaging pattern can look similar across several different diseases, and even experienced radiologists sometimes disagree about whether what they are seeing truly qualifies as honeycombing versus other forms of cystic change. This is one reason that the field has moved toward multidisciplinary team meetings, where pulmonologists, radiologists, and pathologists review cases together. Studies have shown that this collaborative approach improves diagnostic confidence and helps guide treatment decisions more reliably than any single specialist working alone.7PubMed Central. Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives
Even with a team, some cases remain genuinely unclassifiable. When the imaging, lab results, and clinical picture do not line up neatly with a single diagnosis, experts may need to weigh various features on a case-by-case basis to decide on the most appropriate treatment path.8European Respiratory Journal. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease This is frustrating for patients who want a clear-cut answer, but the honest reality is that lung fibrosis does not always sort itself into tidy categories. A working diagnosis that guides treatment is sometimes the best first step.
Why the Extent of Honeycombing Matters for Prognosis
Not all honeycombing carries the same prognosis. The amount of lung affected makes a substantial difference in survival. In one study of patients with combined pulmonary fibrosis and emphysema, five-year survival varied dramatically depending on how much honeycombing was visible on CT: about 79% for those with less than 5% of the lung affected, compared to roughly 32% for those with 26 to 50% involvement. Greater honeycombing extent was independently tied to higher mortality even after accounting for other measures of lung function.9PubMed Central. Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema
In patients with IPF specifically, research using computerized measurement of honeycombing area found that those with more extensive cystic change had a median survival of about 1.3 years, compared to 5 years for those with less honeycombing. Honeycombing area was actually a stronger independent predictor of death than standard lung function tests in that analysis.10PubMed Central. Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern A separate study examining tissue samples from lung biopsies and explanted lungs found that patients with honeycombing confirmed under the microscope had roughly double the risk of death compared to fibrosis patients without it, along with a much higher rate of needing lung transplantation.11American Journal of Respiratory and Critical Care Medicine. Histopathologic Honeycombing is Associated With Worse Mortality in Pulmonary Fibrosis
These numbers are sobering, but they describe averages across groups of patients. Individual trajectories vary. Some people with honeycombing remain relatively stable for years, while others decline quickly. Doctors track lung function over time, rather than relying on a single snapshot, to understand where a particular patient sits on that spectrum.
Treatment Options and What They Can Realistically Do
There is no treatment that reverses honeycombing once it has formed. The scar tissue and cystic destruction are permanent. What treatment aims to do instead is slow down further scarring and manage symptoms so that quality of life is preserved as long as possible.
For IPF, two antifibrotic medications, pirfenidone and nintedanib, are the backbone of drug therapy. Neither cures the disease, and their ability to halt progression is limited, but both have been shown to slow the rate at which lung function declines.12PubMed Central. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF There is no cure yet, and the efficacy of these drugs remains suboptimal, but they represent the best pharmacological tools currently available.13PubMed. Pirfenidone and nintedanib exert additive antifibrotic effects by the SPP1-AKT pathway in macrophages and fibroblasts A systematic review found similar effectiveness between the two agents, and their benefits extend to progressive fibrosis from causes other than IPF as well, suggesting that the underlying scarring process shares common pathways regardless of the initial trigger.14PubMed Central. A Comparison of the Effectiveness of Nintedanib and Pirfenidone in Treating Idiopathic Pulmonary Fibrosis
For fibrosis driven by autoimmune conditions, immunosuppressive drugs may be used alongside or instead of antifibrotics. The specific regimen depends on the underlying disease, which is another reason getting the diagnosis right matters so much.
Supportive Care and Rehabilitation
Beyond medication, several supportive measures can meaningfully improve daily life. Supplemental oxygen is prescribed when blood oxygen levels drop too low, particularly during exertion or sleep. Home oxygen therapy can ease breathlessness and help maintain the ability to stay active, with evidence that it improves quality of life and reduces the burden of exercise-related oxygen drops in people with interstitial lung disease.15Oxygen. Home Oxygen Therapy (HOT) in Stable Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD): Similarities, Differences and Doubts
Pulmonary rehabilitation, a structured program of supervised exercise and education, is another pillar of care. While most of the rehabilitation data comes from patients with COPD or occupational lung diseases rather than IPF specifically, the benefits of improved exercise tolerance and quality of life appear to carry over across different types of chronic lung disease.16PubMed Central. Pulmonary Rehabilitation Strategies for the Treatment of Pneumoconiosis The instinct to avoid exertion when breathing is difficult is understandable, but controlled exercise under supervision tends to improve stamina and reduce the sense of breathlessness over time.
When Lung Transplant Enters the Conversation
For patients with advanced honeycombing and progressive decline, lung transplantation is the only option that can dramatically change the trajectory. IPF is in fact one of the leading reasons people receive lung transplants worldwide. Because the disease can progress quickly and unpredictably, specialists generally recommend early referral to a transplant center rather than waiting until the patient is in crisis.17PubMed. Lung transplant in idiopathic pulmonary fibrosis
Transplant evaluation is complex and not every patient is a candidate. Age, overall fitness, other medical conditions, and the availability of donor organs all factor in. But for those who do receive a transplant, the procedure can add years of life and substantially restore function. The conversation about transplant should happen well before it becomes the only option left, because the evaluation and waiting process takes time.
Complications That Can Develop Alongside Honeycombing
Pulmonary fibrosis does not stay confined to the lung tissue itself. One of the most serious complications that develops alongside progressive scarring is pulmonary hypertension, a condition where the blood pressure in the arteries feeding the lungs rises to dangerous levels. As scar tissue replaces healthy lung, the blood vessels within it are destroyed or compressed, forcing the right side of the heart to work harder. Pulmonary hypertension is common in patients with pulmonary fibrosis and strongly predicts worse outcomes. Having both conditions together is worse than either one alone.18PubMed Central. Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights19PubMed Central. Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra
There is also a recognized link between honeycombing and lung cancer. In one autopsy study, nearly half of patients with UIP-pattern fibrosis had developed lung cancer. Most of those cancers arose in the peripheral regions of the lung, and about two-thirds were located in or near the honeycombed areas themselves.20PubMed. Pulmonary fibrosis and lung carcinoma: a comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma The abnormal cell turnover and chronic inflammation within honeycombed tissue are thought to create a fertile environment for cancerous changes. This does not mean everyone with honeycombing will develop cancer, but it underscores the importance of ongoing monitoring.
Genetic Factors That Influence Honeycombing
Research over the past decade has uncovered genetic factors that help explain why some people develop more extensive honeycombing than others. One area of particular interest involves telomeres, the protective caps on the ends of chromosomes that shorten with age and cell division. Shorter telomeres have been linked to more severe fibrosis and more extensive honeycombing on imaging in patients with both IPF and chronic hypersensitivity pneumonitis.21PubMed Central. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis
Specific gene variants also play a role. A variation in the MUC5B gene, which is involved in mucus production in the airways, has been associated with a greater extent of honeycombing on CT scans in IPF patients. In a study of a Chinese IPF cohort, both shorter telomere length and a particular MUC5B variant were independently correlated with larger areas of honeycombing.22PubMed Central. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort These findings are still far from translating into routine clinical tools, but they are nudging the field toward a future where blood tests or genetic profiles might help predict who will progress faster and who might respond differently to treatment.
Infections Inside Honeycomb Cysts
The structural changes in honeycombed lungs create vulnerabilities that normal lungs do not face. The thick-walled cysts can trap mucus and provide a sheltered environment for certain organisms. Fungal infections are a particular concern. Aspergillus, a common environmental mold, can colonize honeycomb cysts and form fungal balls called mycetomas. These can cause hemoptysis, or coughing up blood, which is alarming and sometimes dangerous. Bacterial infections also find easier footing in lungs with disrupted architecture and impaired clearance mechanisms.
This means that new or changing symptoms in someone with established honeycombing, such as a shift in the character of their cough, fever, or hemoptysis, warrant prompt medical attention. Not every change reflects disease progression; sometimes it signals an infection that can be treated.